H-1B sponsorship profile: EpiVax, Inc. Across U.S. Department of Labor LCA disclosures, EpiVax, Inc filed 4 Labor Condition Applications covering 4 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 75% (3 certified of 4 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on EpiVax, Inc’s H-1B petitions range from $45,000 at the low end to $71,573 at the high end, with a petition-weighted average of $60,537. That range reflects the mix of occupations the company sponsors, led by Bioinformatics Analyst II (2 petitions at $71,573 avg), followed by Research Scientist and Bioinformatics Analyst. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. EpiVax, Inc is headquartered in Providence, RI under NAICS code 54171, and places H-1B workers across 1 state, most heavily in RI. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where EpiVax, Inc ranks. By H-1B petition volume, EpiVax, Inc is #30,742 of 119,880 employers nationally and #71 of 269 employers headquartered in RI. Both ranks are computed live from the same underlying petition counts, not a separate estimate.